Scout Investments, Inc. Exelixis, Inc. Transaction History

Scout Investments, Inc.

$3.4 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$19.25 - $24.13 $1.2 Million - $1.5 Million	-62,272 Reduced 14.6%	364,385 $8.74 Million
Q3 2023 Nov 09, 2023	SELL	$19.04 - $22.74 $511,509 - $610,910	-26,865 Reduced 5.92%	426,657 $9.32 Million
Q2 2023 Aug 14, 2023	SELL	$18.17 - $20.48 $1.31 Million - $1.47 Million	-71,867 Reduced 13.68%	453,522 $8.67 Million
Q1 2023 May 11, 2023	SELL	$16.3 - $19.41 $8.84 Million - $10.5 Million	-542,256 Reduced 50.79%	525,389 $10.2 Million
Q4 2022 Jan 23, 2023	SELL	$14.96 - $17.39 $1.87 Million - $2.18 Million	-125,171 Reduced 10.49%	1,067,645 $0
Q3 2022 Oct 18, 2022	SELL	$15.68 - $22.27 $3.81 Million - $5.41 Million	-242,750 Reduced 16.91%	1,192,816 $18.7 Million
Q2 2022 Jul 15, 2022	BUY	$17.44 - $23.16 $9,626 - $12,784	552 Added 0.04%	1,435,566 $29.9 Million
Q1 2022 Apr 14, 2022	SELL	$17.03 - $22.67 $725,188 - $965,356	-42,583 Reduced 2.88%	1,435,014 $32.5 Million
Q4 2021 Jan 14, 2022	BUY	$15.84 - $21.88 $3.12 Million - $4.3 Million	196,673 Added 15.35%	1,477,597 $27 Million
Q3 2021 Oct 13, 2021	SELL	$16.3 - $21.14 $317,051 - $411,194	-19,451 Reduced 1.5%	1,280,924 $27.1 Million
Q2 2021 Jul 23, 2021	BUY	$17.95 - $25.56 $15.5 Million - $22.1 Million	864,073 Added 198.04%	1,300,375 $23.7 Million
Q1 2021 Apr 09, 2021	SELL	$20.53 - $25.22 $13.9 Million - $17.1 Million	-676,750 Reduced 60.8%	436,302 $9.86 Million
Q4 2020 Jan 12, 2021	BUY	$18.39 - $24.8 $7.77 Million - $10.5 Million	422,256 Added 61.13%	1,113,052 $22.3 Million
Q3 2020 Oct 13, 2020	BUY	$20.67 - $26.94 $14.3 Million - $18.6 Million	690,796 New	690,796 $16.9 Million
Q2 2018 Jul 16, 2018	SELL	$18.56 - $22.45 $9.7 Million - $11.7 Million	-522,761 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$22.15 - $31.89 $1.36 Million - $1.96 Million	-61,398 Reduced 10.51%	522,761 $11.6 Million
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $14.2 Million - $18.1 Million	584,159	584,159 $17.8 Million

Others Institutions Holding EXEL

# of Institutions

501

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

Black Rock Inc. New York, NY

33.5M
Shares

$1.19 Billion
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

29.3M
Shares

$1.04 Billion
0.01% of portfolio
Farallon Capital Management LLC San Francisco, CA

25.4M
Shares

$905 Million
3.31% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

15.4M
Shares

$547 Million
0.63% of portfolio
State Street Corp Boston, MA

11.4M
Shares

$408 Million
0.01% of portfolio

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.5B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scout Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scout Investments, Inc. with notifications on news.

Account